Device Trial Radar · NCT07073950
A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation
Last checked: Nov 20, 2026Latest source record: Sep 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
56
Planned (sponsor's estimate)
Start
Nov 24, 2025
Primary completion
May 31, 2027
Study completion May 31, 2027
Sponsor
- Lead sponsor
- AstraZenecaNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Parexel
- First posted
- Jul 20, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the effect of BGF MDI compared with placebo MDI on cardiac and lung function when administered in participants diagnosed with COPD and hyperinflation.
Conditions
- Chronic Obstructive Pulmonary Disease
- Hyperinflation
Interventions
Budesonide/Glycopyrronium/Formoterol FumarateDrug
BGF will be administered as 2 inhalations via oral route of administration
PlaceboDrug
Matching placebo will be administered as 2 inhalations via oral route of administration
Metered dose inhalerDevice
Participants will receive BGF and matching placebo via metered dose inhaler in treatment periods of the study.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in left ventricular end diastolic volume indexed by body surface area (LVEDVi) measured by magnetic resonance imaging (MRI)Time frame: Up to 3 weeks
Locations
7 sites in 2 countries. Site status is shown where the registry gives one.
Research Site
Ahrensburg, Germany · Recruiting
Research Site
Berlin, Germany · Recruiting
Research Site
Frankfurt, Germany · Recruiting
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.